Stephen H. Blose

Following his doctoral training in molecular biology and medicine at the University of Pennsylvania, Dr. Blose joined Cold Spring Harbor Laboratory as a Senior Scientist working for Nobel Laureate Dr. James D. Watson in cancer research. He then joined Protein Databases, Inc. (PDI), eventually becoming the CEO, and, during his tenure, developed significant relationships with Millipore (now MilliporeSigma, Merck KGaA, Darmstadt), Pharmacia LKB Biotechnology (now GE Healthcare) and Toyobo Co., Ltd. PDI was acquired by Bio-Rad Laboratories Inc., a $2.5-billion company, and Dr. Blose became General Manager of their Imaging Products Division. He later founded the Mill Valley Summit Group, LLC, a transaction advisory group, that successfully helped early-stage companies in life science products and medical devices raise more than $150-million from venture financing, licensing deals, and asset transactions. Dr. Blose is former Chairman of the Board at BioMicro Systems Inc. (acquired by Hoffmann-La Roche Ltd.), former Board Director and Board Secretary of Sentrx Animal Care, Inc., and, he is regarded as a founder of the proteomics industry. Dr. Blose secretary to Lumiphore’s board of directors.